Synthesis and H1-antihistaminic activity of some novel 1-substituted-4-(3-methylphenyl)-1,2,4-triazolo[4,3-a]quinazolin-5(4H)-ones.

作者: Veerachamy Alagarsamy , Rajani Giridhar , Mangae Ram Yadav

DOI: 10.1248/BPB.28.1531

关键词:

摘要: A series of novel 1-substituted-4-(3-methylphenyl)-1,2,4-triazolo[4,3-a]quinazolin-5(4H)-ones were synthesized by the cyclization 2-hydrazino-3-(3-methylphenyl) quinazolin-4(3H)-one with various one carbon donors. The starting material 2-hydrazino-3-(3-methylphenyl)quinazolin-4(3H)-one, was from 3-methylaniline a innovative route. When tested for their in vivo H1-antihistaminic activity on conscious guinea pigs, all test compounds protected animals histamine induced bronchospasm significantly, whereas compound 1-methyl-4-(3-methylphenyl)-1,2,4-triazolo[4,3-a]quinazolin-5(4H)-one II found to be equipotent (percent protection 70.0%) reference standard chlorpheniramine maleate 71%). Compound show negligible sedation (7%) when compared (25%). Hence it could serve as prototype molecule further development new class H1-antihistamines.

参考文章(6)
Elliot F. Ellis, Elliott Middleton, Charles E. Reed, Allergy, principles and practice Mosby. ,(1978)
J. K. Peat, The rising trend in allergic illness: which environmental factors are important? Clinical & Experimental Allergy. ,vol. 24, pp. 797- 800 ,(1994) , 10.1111/J.1365-2222.1994.TB01802.X
Toyoko Nakagomi, Hideki Itaya, Tooru Tominaga, Mitsuo Yamaki, Shun-ichi Hisamatsu, Osamu Nakagomi, Is atopy increasing The Lancet. ,vol. 343, pp. 121- 122 ,(1994) , 10.1016/S0140-6736(94)90854-0
M MCCALL, N NAIR, S WONG, R TOWNLEY, D LANG, S WEISS, 256 Double-blind controlled safety and efficacy trial of SK&F 93944 The Journal of Allergy and Clinical Immunology. ,vol. 75, pp. 168- ,(1985) , 10.1016/0091-6749(85)90391-4
E. F. Van Maanen, W. L. Kuhn, Central nervous system effects of thalidomide. Journal of Pharmacology and Experimental Therapeutics. ,vol. 134, pp. 60- 68 ,(1961)